JDWRX
Price
$127.60
Change
+$0.74 (+0.58%)
Updated
Sep 26 closing price
Net Assets
4.36B
RNPCX
Price
$70.47
Change
+$0.37 (+0.53%)
Updated
Sep 26 closing price
Net Assets
161.39B
Interact to see
Advertisement

JDWRX vs RNPCX

Header iconJDWRX vs RNPCX Comparison
Open Charts JDWRX vs RNPCXBanner chart's image
Janus Henderson Global Research R
Price$127.60
Change+$0.74 (+0.58%)
VolumeN/A
Net Assets4.36B
American Funds New Perspective R3
Price$70.47
Change+$0.37 (+0.53%)
VolumeN/A
Net Assets161.39B
JDWRX vs RNPCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JDWRX vs. RNPCX commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDWRX is a Hold and RNPCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 161B vs. JDWRX (4.36B). RNPCX pays higher dividends than JDWRX: RNPCX (0.22) vs JDWRX (0.00). JDWRX was incepted earlier than RNPCX: JDWRX (13 years) vs RNPCX (23 years). JDWRX (1.40) is less costly to investors than RNPCX (1.06). JDWRX is a more actively managed with annual turnover of: 28.00 vs. RNPCX (24.00). RNPCX has a lower initial minimum investment than JDWRX: RNPCX (250) vs JDWRX (2500). RNPCX (10.33) and JDWRX (9.95) have marching annual gain over last year. JDWRX return over 5 years is better than : 47.68 vs. RNPCX (38.43).
JDWRXRNPCXJDWRX / RNPCX
Total Expense Ratio1.401.06132%
Annual Report Gross Expense Ratio1.401.06132%
Fund Existence13 years23 years-
Gain YTD17.10717.31399%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.36B161B3%
Annual Yield % from dividends0.000.22-
Returns for 1 year9.9510.3396%
Returns for 3 years71.7360.20119%
Returns for 5 years47.6838.43124%
Returns for 10 years123.08107.40115%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APDN4.141.23
+42.27%
Applied DNA Sciences Inc
SLDB6.150.23
+3.89%
Solid Biosciences
EVTC34.110.34
+1.01%
EVERTEC
BSAC26.350.12
+0.46%
Banco Santander-Chile
TSE2.48-0.09
-3.50%
Trinseo PLC